XBI formed a double bottom. The bulls made a stand at this level. Appears to be in a rectangle which is a neutral pattern until a trendline is broken with a trend in that direction.
The top trendline of a rectangle is resistance. The bottom is support. It is a horizontal trading channel and price can bounce back and forth until a trendline is broken.
No recommendation.
SPDR Series Trust - SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Benchmark: S&P Biotechnology Select Industry TR USD.
Top 10 Holdings
Intellia Therapeutics Inc
1.15%
Moderna Inc
1.12%
Cytokinetics Inc
0.98%
Celldex Therapeutics Inc
0.91%
Translate Bio Inc
0.90%
Arcus Biosciences Inc
0.87%
Veracyte Inc
0.85%
ChemoCentryx Inc
0.84%
Biohaven Pharmaceutical Holding Co Ltd
0.83%
Kymera Therapeutics Inc Ordinary Shares
The top trendline of a rectangle is resistance. The bottom is support. It is a horizontal trading channel and price can bounce back and forth until a trendline is broken.
No recommendation.
SPDR Series Trust - SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Benchmark: S&P Biotechnology Select Industry TR USD.
Top 10 Holdings
Intellia Therapeutics Inc
1.15%
Moderna Inc
1.12%
Cytokinetics Inc
0.98%
Celldex Therapeutics Inc
0.91%
Translate Bio Inc
0.90%
Arcus Biosciences Inc
0.87%
Veracyte Inc
0.85%
ChemoCentryx Inc
0.84%
Biohaven Pharmaceutical Holding Co Ltd
0.83%
Kymera Therapeutics Inc Ordinary Shares